Biomarkers for minimally invasive multigrade liver cancer diagnosis using integrative heterogeneous models and evolutionary algorithms
- 10 July 2026
- journal article
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 124 (Pt 2) , 109225
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Serum Fusion Transcripts to Assess the Risk of Hepatocellular Carcinoma and the Impact of Cancer Treatment through Machine LearningThe American Journal of Pathology, 2024
- MRI imaging features for predicting macrotrabecular-massive subtype hepatocellular carcinoma: a systematic review and meta-analysisEuropean Radiology, 2024
- Novel Blood-Based Biomarkers for HCCCurrent Hepatology Reports, 2024
- SMOTE-NC and gradient boosting imputation based random forest classifier for predicting severity level of covid-19 patients with blood samplesNeural Computing and Applications, 2021
- An imageomics and multi-network based deep learning model for risk assessment of liver transplantation for hepatocellular cancerComputerized Medical Imaging and Graphics, 2021
- Artificial intelligence in assessment of hepatocellular carcinoma treatment responseAbdominal Radiology, 2021
- Cancer diagnostics based on plasma protein biomarkers: hard times but great expectationsMolecular Oncology, 2020
- Machine learning applications in cancer prognosis and predictionComputational and Structural Biotechnology Journal, 2014
- Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: New aspects and applicationsClinica Chimica Acta, 2008
- Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: A systematic reviewHepatology, 2002